Propranolol increases the complexity of heart rate fluctuations - A mode of antiarrhythmic action?

International Journal of Clinical Pharmacology and Therapeutics

Volumn 43, Issue 2, 2005, Pages 101-108

  Lepoluoto, Ahto ^a,b   Nino, J ^a,b   Tahvanainen, K ^b   Ylitalo, R ^a,b   Kuusela, T ^c   Kahonen M ^a,b   Kaila, T ^d  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d Kuusamo Health Center   (Finland)

Author keywords

Heart rate and blood pressure fluctuations; Linear and nonlinear time series analysis; Propranolol

Indexed keywords

PLACEBO; PROPRANOLOL;

ADULT; ANTIARRHYTHMIC ACTIVITY; ARTERIAL PRESSURE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD VESSEL TONE; BREATHING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR REFLEX; CHOLINERGIC SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG TOLERABILITY; ELECTROCARDIOGRAPHY; ENTROPY; FEMALE; FRACTAL ANALYSIS; FREQUENCY ANALYSIS; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; LINEAR SYSTEM; MALE; MATHEMATICAL MODEL; NONLINEAR SYSTEM; NORMAL HUMAN; PRESSORECEPTOR REFLEX; RANDOMIZED CONTROLLED TRIAL; RECORDING; RR INTERVAL; SIDE EFFECT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TIME SERIES ANALYSIS;

EID: 14544291997     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP43101     Document Type: Article

References (36)

1. Chen X, Hassan MO, Jones JV, Sleight P, Floras JS 1999 Baroreflex sensitivity and the blood pressure response to β-blockade. J Hum Hypertens 13: 185-190
2. Coodley EL 1971 Clinical indications for propranolol. Am Fam Physician 4: 84-89
3. Cooke WH, HJoag JB Crossmann AA, Kuusela TA, Tahvanainen KU, Eckberg DL 1999 Human responses to upright tilt: a window on central autonomic integration. J Physiol 517: 617-628
4. Dekker JM, Schouten EG, Klootwijk P, Pool J, Swenne CA, Kromhout D 1997 Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol 15: 899-908
5. Eckberg DL, Drabinsky M, Braunwald E 1971 Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 14: 877-883
6. Floras JS, Jones JV, Hassan MO, Sleight P 1988 Effects of acute and chronic β-adrenoceptor blockade on baroreflex sensitivity in humans. J Auton Nerv Syst 25: 87-94
7. Gleiter CH, Deckert J 1996 Adverse CNS effects of β-adrenoceptor blockers. Pharmacopsychiatry 29: 201-211
8. Haberthur C, Schachinger H, Langewitz W, Ritz R 1999 Effect of β-blockade with and without sympathomimetic activity (ISA) on sympathovagal balance and baroreflex sensitivity. Clin Physiol 19: 143-152
9. Hasking GJ, Esler MD, Jennings GL, Burton D, Korner PI 1986 Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73: 615-621
10. Hohnloser SH, Klingenheben T, Zabel M, Just H 1993 Effect of sotalol on heart rate variability assessed by Holter monitoring in patients with ventricular arrhythmias. Am J Cardiol 72: 67A-71A
11. Huikuri HV, Seppanen T, Koistinen MJ, Airaksinen J, Ikaheimo MJ, Castellanos A, Myerburg RJ 1996 Abnormalities in beat-to-beat dynamics of heart rate before the spontaneous onset of life-threatening ventricular tachyarrhythmias in patients with prior myocardial infarction. Circulation 93: 1836-1844
12. Jartti TT, Kuusela TA, Kaila TJ, Tahvanainen KU, Valimaki IA 1998 The dose-response effects of terbutaline on the variability, approximate entropy and fractal dimension of heart rate and blood pressure. Br J Clin Pharmacol 45: 277-285
13. 1-selective β-blockers on arterial pulse wave velocity in normotensive subjects. Gen Pharmacol 35: 219-224
14. Kantz H, Schreiber T 1995 Dimension estimates and physiological data. Chaos 5: 143-154
15. Koch-Weser J, Frishman WH 1981 β-Adrenoceptor antagonists: new drugs and new indications. N Engl J Med 305: 500-506
16. Koebe P, Rost R, Teinke A, Nagel N, Merten U 1985 Effects of various beta-receptor blockkers on metabolic and circulatory parameters during physical exertion. Arzneimittelforschung 2: 522-529
17. Kuusela TA, Jartti TT, Tahvanainen KU, Kaila TJ 2002 Nonlinear methods of biosignal analysis in assessing terbutaline-induced heart rate and blood pressure changes. Am J Physiol Heart Circ Physiol 282: 773-783
18. Lampert R, Ickovics JR, Viscoli CJ, Horwitz RI, Lee FA 2003 Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the β-Blocker Heart Attack Trial. Am J Cardiol 91: 137-142
19. Leimbach WN Jr, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL 1986 Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73: 913-919
20. Lewis PJ 1976 β-Receptor blockade hypotension and the central nervous system. Clin Sci Mol Med Suppl 3: 549-556
21. Mark A 1995 Sympathetic dysregulation in heart failure: mechanisms and therapy. Clin Cardiol 18: 13-18
22. McDevitt DG 1989 In vivo studies of cardiac β-adrenoceptors in man. Eur Heart J 10: 22-28
23. Newman-Tancredi A, Conte C, Chaput C, Verriele L, Audinot-Bouchez V, Lochon S, Lavielle G, Millan MJ 1997 Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy Naunyn Schmiedebergs Arch Pharmacol 355: 682-688
24. Ogawa J, Takata S, Aoki K, Oukuwa H, Iwase N, Ikeda T, Hattori N 1989 Acute changes in the properties of baroreflexes in man after β-blockade. Clin Exp Pharmacol Physiol 15: 125-128
25. Omboni S, Parati G, Frattola A, Mutti E, Di Rienzo M, Castiglioni P, Mancia G 1993 Spectral and sequence analysis of finger blood pressure variability: comparison with analysis of intra-arterial recordings. Hypertension 22: 26-33
26. Osterziel KJ, Hanlein D, Willenbrock R, Eichhorn C, Luft F, Dietz R 1995 Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure. Br Heart J 73: 517-522
27. Parati G, Mutti E, Frattola A, Castiglioni P, di Rienzo M, Mancia G 1994 β-Adrenergic blocking treatment and 24-hour baroreflex sensitivity in essential hypertensive patients. Hypertension 23: 992-996
28. Pincus SM, Goldberger AL 1994 Physiological time-series analysis: what does regularity quantify? Am J Physiol 266: 1643-1656
29. Richman JS, Moorman JR 2000 Physiological time-series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol 278: 2039-2049
30. Robbe HW, Mulder LJ, Ruddel H, Langewitz WA, Veldman JB, Mulder G 1987 Assessment of baroreceptor reflex sensitivity by means of spectral analysis. Hypertension 10: 538-543
31. Task Force for the European Society of Cardiology and the North American Society of Pacing and Electrophysiology 1996 Heart Rate Variability. Standards of measurement, physiological interpretation and clinical use. Circulation 93: 1043-1065
32. Vaile JC, Fletcher J, Al-Ani M, Ross HF, Littler WA, Coote JH, Townend JN 1999 Use of opposing reflex stimuli and heart rate variability to examine the effects of lipophilic and hydrophilic β-blockers on human cardiac vagal control. Clin Sci (Lond) 97: 609-610
33. van Ravenswaaij-Arts CMA, Kollèe LAA, Hopman JCW, Stoelinga GBA, van Geijn HP 1993 Heart rate variability. Ann Intern Med 118: 436-447
34. Voss A, Kurths J, Kleiner HJ, Witt A, Wessel N 1995 Improved analysis of heart rate variability by methods of nonlinear dynamics. J Electrocardiol 28: 81-88
35. Voss A, Kurths J, Kleiner HJ, Witt A, Wessel N, Saparin P, Osterziel KJ, Schurath R, Dietz R 1996 The application of methods of nonlinear dynamics for the improved and predictive recognition of patients threatened by sudden cardiac death. Cardiovasc Res 31: 419-433
36. Wellstein A, Palm D, Pitschner HF, Belz GG 1985 Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man. Eur J Clin Pharmacol 29: 131-147